CXCR4 and colorectal cancer: Recent PNAS study reported that CXCR4 inhibition in combination with blockade of the PD-1/PD-L1 induced T cell infiltration and anticancer responses in human pancreatic and colorectal cancers (Biasci et al., 2020).